Dr Reddys Profile

Performance

Odds of Distress

11%11%
Analyze Filter    Check how we calculate scores
Equity ratings for Dr Reddys Laboratories Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 10, 2019 and ending today December 9, 2019. Click here to learn more.

Dr Reddys Profile

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people. more
NameDr Reddys Laboratories Ltd
CEOMARC KIKUCHIView All
Thematic Classification
Currently Active Investing Idea
  Obamacare
View All
Analyst Consensus
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business Address8-2-337, Road No. 3
ExchangeBATS Exchange
ISINUS2561352038
SectorHealthcare
IndustryDrug Manufacturers?Specialty & Generic
BenchmarkDOW
Websitewww.drreddys.com
Phone91 40 4900 2900
CurrencyUSD - US Dollar
Next Fiscal Year EndMarch 31, 2021
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndMarch 31, 2019
Date Short InterestNovember 15, 2019
Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people. The company currently falls under 'Mid-Cap' category with total capitalization of 6.62 B. Dr Reddys Laboratories runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 165.75 M outstanding shares of which 1.6 M shares are at this time shorted by investors with about 8.76 days to cover shorted positions. DR. REDDY'S LAB L has about 283.41 M in cash with 75.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check Dr Reddys Probability Of Bankruptcy

Ownership Allocation (%)

Dr Reddys Target Price Odds Analysis

Odds Below 40.42HorizonTargetOdds Above 40.42
90.52%30 days 40.42 9.32%
Based on normal probability distribution, the odds of Dr Reddys to move above current price in 30 days from now is about 9.32 (This Dr Reddys Laboratories Ltd probability density function shows the probability of Dr Reddys Stock to fall within a particular range of prices over 30 days) .

Dr Reddys Laboratories Top Holders

Dr Reddys Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Royal Bank Of CanadaCommon Shares4.3 M164.7 M
Blackrock IncCommon Shares1.7 M65.1 M
View Dr Reddys Diagnostics

Dr Reddys Laboratories Risk Profiles

Dr Reddys Key Fundamentals

Dr Reddys Against Markets

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Dr Reddys Corporate Directors

Hans Hasler Additional Independent Director
Leo Puri Non-Executive Independent Director
Ravi Bhoothalingam Non-Executive Independent Director
Additionally take a look at Your Equity Center. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Search macroaxis.com